Disorders of Electrolytes

  • Flávio Eduardo Nácul


Disorders of electrolytes are common in critically ill surgical patients. This chapter will discuss the etiology, diagnosis, and management of abnormalities of sodium, potassium, magnesium, calcium, and phosphorous.


Diabetes Insipidus Plasma Osmolality Urine Osmolality Serum Osmolality Magnesium Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med. 1986;81:1033–1040.PubMedCrossRefGoogle Scholar
  2. 2.
    Chung HM, Kluge R, Schrier RW, Anderson RJ. Postoperative hyponatremia. A prospective study. Arch Intern Med. 1986;146:333–336.PubMedCrossRefGoogle Scholar
  3. 3.
    Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine. 1976;55:121–129.PubMedCrossRefGoogle Scholar
  4. 4.
    Sterns RH. Severe hyponatremia: the case for conservative management. Crit Care Med. 1992;20:534–539.PubMedCrossRefGoogle Scholar
  5. 5.
    Arieff AI, Ayus JC. Pathogenesis of hyponatremic encephalopathy. Current concepts. Chest. 1993;103:607–610.PubMedCrossRefGoogle Scholar
  6. 6.
    Verbalis JG. Hyponatremia: epidemiology, pathophysiology, and therapy. Curr Opin Nephrol Hypertens. 1993;2:636–652.PubMedCrossRefGoogle Scholar
  7. 7.
    Zarinetchi F, Berl T. Evaluation and management of severe hyponatremia. Adv Intern Med. 1996;41:251–283.PubMedGoogle Scholar
  8. 8.
    Istre O, Bjoennes J, Hornbaek K, Forman A. Postoperative cerebral oedema after transcervical endometrial resection and uterine irrigation with 1.5% glycine. Lancet. 1994;344:1187–1189.PubMedCrossRefGoogle Scholar
  9. 9.
    Hoorn EJ, Zietse R. Hyponatremia revisited: translating physiology to practice. Nephron Physiol. 2008;108:46–59.CrossRefGoogle Scholar
  10. 10.
    Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349:245–249.PubMedCrossRefGoogle Scholar
  11. 11.
    Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42:790–806.PubMedCrossRefGoogle Scholar
  12. 12.
    Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23:529–542.PubMedCrossRefGoogle Scholar
  13. 13.
    Tang WW, Kaptein EM, Feinstein EI, Massry SG. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med. 1993;94:169–174.PubMedCrossRefGoogle Scholar
  14. 14.
    Lokich JJ. The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinoma. Cancer. 1982;50:2111–2114.PubMedCrossRefGoogle Scholar
  15. 15.
    Beck LH. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med. 1979;301:528–530.PubMedCrossRefGoogle Scholar
  16. 16.
    Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14(4):182–187.PubMedCrossRefGoogle Scholar
  17. 17.
    Cerda-Esteve M, Cuadrado-Godia E, Chillaron JJ, et al. Cerebral salt wasting syndrome: review. Eur J Intern Med. 2008;19(4):249–254.PubMedCrossRefGoogle Scholar
  18. 18.
    Patel GP, Balk R. Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clin Ther. 2007;29:211–229.PubMedCrossRefGoogle Scholar
  19. 19.
    Oster JR, Singer I. Hyponatremia, hypoosmolality, and hypotonicity: tables and fables. Arch Intern Med. 1999;159:333–336. antigamente 20.PubMedCrossRefGoogle Scholar
  20. 20.
    Adler SM, Verbalis JG. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin N Am. 2006;35:873–894.CrossRefGoogle Scholar
  21. 21.
    Katz MA. Hyperglycemia-induced hyponatremia – calculation of expected serum sodium depression. N Engl J Med. 1973;289:843–844.PubMedCrossRefGoogle Scholar
  22. 22.
    Hillier TA, Abbot RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106:399–403.PubMedCrossRefGoogle Scholar
  23. 23.
    Ellison DH, Berl T. The syndrome of innappropriate antidiuresis. N Engl J Med. 2007;356:2064–2072.PubMedCrossRefGoogle Scholar
  24. 24.
    Chen S, Jalandhara N, Batlle D. Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists. Nat Clin Pract Nephrol. 2007;3(2):82–95.PubMedCrossRefGoogle Scholar
  25. 25.
    Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008;371:1624–1632.PubMedCrossRefGoogle Scholar
  26. 26.
    Ali F, Raufi MA, Washington B, Ghali JK. Conivaptan: a dual vasopressin receptor v1a/v2 antagonist. Cardiovasc Drug Rev. 2007;25(3):261–279.PubMedCrossRefGoogle Scholar
  27. 27.
    Decaux G, Brimioulle S, Genette F, Mockel J. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med. 1980;69:99–106.PubMedCrossRefGoogle Scholar
  28. 28.
    Decaux G, Genette F. Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. Br Med J (Clin Res Ed). 1981;283:1081–1083.CrossRefGoogle Scholar
  29. 29.
    Reeder RF, Harbaugh RE. Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J Neurosurg. 1989;70:201–206.PubMedCrossRefGoogle Scholar
  30. 30.
    Mulloy AL, Caruana RJ. Hyponatremic emergencies. Med Clin North Am. 1995;79:155–168.PubMedGoogle Scholar
  31. 31.
    Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342:1493–1499.PubMedCrossRefGoogle Scholar
  32. 32.
    Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med. 1987;317:1190–1195.PubMedCrossRefGoogle Scholar
  33. 33.
    Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891–897.PubMedCrossRefGoogle Scholar
  34. 34.
    Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–1542.PubMedCrossRefGoogle Scholar
  35. 35.
    Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. 1997;126:57–62.PubMedCrossRefGoogle Scholar
  36. 36.
    Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol. 1999;51:383–386.PubMedGoogle Scholar
  37. 37.
    Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med. 1996;124:197–203.PubMedCrossRefGoogle Scholar
  38. 38.
    Snyder NA, Feigal DW, Arieff AI. Hypernatremia in elderly patients. A heterogeneous, morbid, and iatrogenic entity. Ann Intern Med. 1987;107:309–319.PubMedCrossRefGoogle Scholar
  39. 39.
    Polderman KH, Schreuder WO, Strack van Schijndel RJ, Thijs LG. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999;27:1105–1108.PubMedCrossRefGoogle Scholar
  40. 40.
    Rose BD. Clinical physiology of acid-base and electrolyte disorders. 4th ed. New York: McGraw-Hill; 1994.Google Scholar
  41. 41.
    Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17(4):471–503.PubMedCrossRefGoogle Scholar
  42. 42.
    Gullans SR, Verbalis JG. Control of brain volume during hyperosmolar and hypoosmolar conditions. Annu Rev Med. 1993;44:289–301.PubMedCrossRefGoogle Scholar
  43. 43.
    Halperin ML, Kamel KS. Potassium. Lancet. 1998;352:135–140.PubMedGoogle Scholar
  44. 44.
    Kumar S, Berl T. Sodium. Lancet. 1998;352:220–228.PubMedCrossRefGoogle Scholar
  45. 45.
    Gennari FJ. Hypokalemia. N Engl J Med. 1998;339:451–458.PubMedCrossRefGoogle Scholar
  46. 46.
    Ethier JH, Kamel KS, Magner PO, et al. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney. 1990;15:309–315.Google Scholar
  47. 47.
    Kamel KS, Quaggin S, Scheich A, Halperin ML. Disorders of potassium homeostasis: an approach based on pathophysiology. Am J Kidney Dis. 1994;24:597–613.PubMedGoogle Scholar
  48. 48.
    Clark BA, Brown RS. Potassium homeostasis and hyperkalemic syndromes. Endocrinol Metab Clin North Am. 1995;24:573–591.PubMedGoogle Scholar
  49. 49.
    Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246–3251.PubMedCrossRefGoogle Scholar
  50. 50.
    Quamme GA, Dirks JH. Magnesium metabolism. In: Narins RG, editor. Maxwell & Kleeman’s clinical disorders of fluid and electrolyte metabolism. 5th ed. New York: McGraw-Hill; 1994. p. 373–397.Google Scholar
  51. 51.
    Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet. 1998;352:391–396.PubMedCrossRefGoogle Scholar
  52. 52.
    Wacker WE, Parisi AF. Magnesium metabolism. N Engl J Med. 1968;278:658–663.PubMedCrossRefGoogle Scholar
  53. 53.
    Elin RJ. Assessment of magnesium status. Clin Chem. 1987;33:1965–1970.PubMedGoogle Scholar
  54. 54.
    Matz R. Magnesium: deficiencies and therapeutic uses. Hosp Pract (Off Ed). 1993;28:79–82,85–87,91–92.Google Scholar
  55. 55.
    Fiaccadori E, Del Canale S, Coffrini E, et al. Muscle and serum magnesium in pulmonary intensive care unit patients. Crit Care Med. 1988;16:751–760.PubMedCrossRefGoogle Scholar
  56. 56.
    Quamme GA, Dirks JH. The physiology of renal magnesium handling. Ren Physiol. 1986;9:257–269.PubMedGoogle Scholar
  57. 57.
    Nadler JL, Rude RK. Disorders of magnesium metabolism. Endocrinol Metab Clin North Am. 1995;24:623–641.PubMedGoogle Scholar
  58. 58.
    Elisaf M, Milionis H, Siamopoulus KC. Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics. Miner Electrolyte Metab. 1997;23:105–112.PubMedGoogle Scholar
  59. 59.
    Hamill-Ruth RJ, McGory R. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial. Crit Care Med. 1996;24:38–45.PubMedCrossRefGoogle Scholar
  60. 60.
    Chernow B, Bamberger S, Stoiko M, et al. Hypomagnesemia in patients in postoperative intensive care. Chest. 1989;95:391–397.PubMedCrossRefGoogle Scholar
  61. 61.
    Rubeiz GJ, Thill-Baharozian M, Hardie D, Carlson RW. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med. 1993;21:203–209.PubMedCrossRefGoogle Scholar
  62. 62.
    Safavi M, Honarmand A. Admission hypomagnesemia – impact on mortality or morbidity in critically ill patients. Middle East J Anesthesiol. 2007;19(3):645–660.PubMedGoogle Scholar
  63. 63.
    Salem M, Kasinski N, Munoz R, Chernow B. Progressive magnesium deficiency increases mortality from endotoxin challenge: protective effects of acute magnesium replacement therapy. Crit Care Med. 1995;23:108–118.PubMedCrossRefGoogle Scholar
  64. 64.
    Hersh T, Siddiqui DA. Magnesium and the pancreas. Am J Clin Nutr. 1973;26:362–366.PubMedGoogle Scholar
  65. 65.
    Kingston ME, Al-Siba’i MB, Skooge WC. Clinical manifestations of hypomagnesemia. Crit Care Med. 1986;14:950–954.PubMedCrossRefGoogle Scholar
  66. 66.
    Boyd JC, Bruns DE, Wills MR. Frequency of hypomagnesemia in hypokalemic states. Clin Chem. 1983;29:178–179.PubMedGoogle Scholar
  67. 67.
    Olerich MA, Rude RK. Should we supplement magnesium in critically ill patients? New Horiz. 1994;2:186–192.PubMedGoogle Scholar
  68. 68.
    Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med. 1992;152:40–45.PubMedCrossRefGoogle Scholar
  69. 69.
    Reinhart RA. Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med. 1988;148:2415–2420.PubMedCrossRefGoogle Scholar
  70. 70.
    Ryzen E, Elbaum N, Singer FR, Rude RK. Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium. 1985;4:137–147.PubMedGoogle Scholar
  71. 71.
    Hébert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P. Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test. Crit Care Med. 1997;25:749–755.PubMedCrossRefGoogle Scholar
  72. 72.
    Gries A, Bode C, Gross S, Peter K, Bohrer H, Martin E. The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery. Anesth Analg. 1999;88:1213–1219.PubMedGoogle Scholar
  73. 73.
    Fuentes A, Rojas A, Porter KB, Saviello G, O’Brien WF. The effect of magnesium sulfate on bleeding time in pregnancy. Am J Obstet Gynecol. 1995;173:1246–1249.PubMedCrossRefGoogle Scholar
  74. 74.
    Dhingra S, Solven F, Wilson A, McCarthy DS. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis. 1984;129:497–498.PubMedGoogle Scholar
  75. 75.
    Whang R, Flink EB, Dyckner T, Wester PO, Aikawa KK, Ryan MP. Magnesium depletion as a cause of refractory potassium repletion. Arch Intern Med. 1985;145:1686–1689.PubMedCrossRefGoogle Scholar
  76. 76.
    al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis. 1994;24:737–752.PubMedGoogle Scholar
  77. 77.
    Ryzen E, Nelson TA, Rude RK. Low blood mononuclear cell magnesium content and hypocalcemia in normomagnesemic patients. West J Med. 1987;147:549–553.PubMedGoogle Scholar
  78. 78.
    Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20(1):3–17.PubMedCrossRefGoogle Scholar
  79. 79.
    Ryzen E. Magnesium homeostasis in critically ill patients. Magnesium. 1989;8:201–212.PubMedGoogle Scholar
  80. 80.
    Lind L, Carlstedt F, Rastad J, et al. Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med. 2000;28:93–99.PubMedCrossRefGoogle Scholar
  81. 81.
    Zaloga GP. Ionized hypocalcemia during sepsis. Crit Care Med. 2000;28:266–268.PubMedCrossRefGoogle Scholar
  82. 82.
    Zaloga GP, Chernow B. Hypocalcemia in critical illness. JAMA. 1986;256:1924–1929.PubMedCrossRefGoogle Scholar
  83. 83.
    Tohme JF, Bilezikian JP. Hypocalcemic emergencies. Endocrinol Metab Clin North Am. 1993;22:363–375.PubMedGoogle Scholar
  84. 84.
    Reber PM, Heath H 3rd. Hypocalcemic emergencies. Med Clin North Am. 1995;79:93–106.PubMedGoogle Scholar
  85. 85.
    Bushinski D, Monk RD. Calcium. Lancet. 1998;352:306–311.CrossRefGoogle Scholar
  86. 86.
    Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008;(4):CD006163.Google Scholar
  87. 87.
    Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med. 2000;342:177–185.PubMedCrossRefGoogle Scholar
  88. 88.
    Bilezikian JP. Management of acute hypercalcemia. N Engl J Med. 1992;326:1196–1203.PubMedCrossRefGoogle Scholar
  89. 89.
    Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med. 1997;103:134–145.PubMedCrossRefGoogle Scholar
  90. 90.
    Nussbaum SR. Pathophysiology and management of severe hypercalcemia. Endocrinol Metab Clin North Am. 1993;22:343–362.PubMedGoogle Scholar
  91. 91.
    Hosking DJ, Cowley A, Bucknall CA. Rehydration in the treatment of severe hypercalcaemia. Q J Med. 1981;50:473–481.PubMedGoogle Scholar
  92. 92.
    Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE. Randomized double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy. Br J Cancer. 1995;72:1289–1293.PubMedCrossRefGoogle Scholar
  93. 93.
    Bilezikian JP. Clinical review 51: management of hypercalcemia. J Clin Endocrinol Metab. 1993;77:1445–1449.PubMedCrossRefGoogle Scholar
  94. 94.
    Hodgson SF, Hurley DL. Acquired hypophosphatemia. Endocrinol Metab Clin North Am. 1993;22:397–409.PubMedGoogle Scholar
  95. 95.
    Knochel JP, Agarwal R. Hypophosphatemia and hyperphosphatemia. In: Brenner BM, editor. Brenner and Rector’s the kidney. 5th ed. Philadelphia: WB Saunders; 1996. p. 1086–1133.Google Scholar
  96. 96.
    Ritz E. Acute hypophosphatemia. Kidney Int. 1982;22(1):84–94.PubMedCrossRefGoogle Scholar
  97. 97.
    Camp MA, Allon M. Severe hypophosphatemia in hospitalized patients. Miner Electrolyte Metab. 1990;16:365–368.PubMedGoogle Scholar
  98. 98.
    Subramanian R, Khardori R. Severe hypophosphatemia. Pathophysiologic implications, clinical presentations and treatment. Medicine. 2000;79:1–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol. 2006;2(3):136–148.PubMedCrossRefGoogle Scholar
  100. 100.
    George R, Shiu MH. Hypophosphatemia after major hepatic resection. Surgery. 1992;111:281–286.PubMedGoogle Scholar
  101. 101.
    Medical staff conference: hypophosphatemia. West J Med. 1975;122:482–489.Google Scholar
  102. 102.
    Betro MG, Pain RW. Hypophosphataemia and hyperphosphataemia in a hospital population. BMJ. 1972;1:273–276.PubMedCrossRefGoogle Scholar
  103. 103.
    Brown GR, Greenwood JK. Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill. Ann Pharmacother. 1994;28:626–632.PubMedGoogle Scholar
  104. 104.
    Desai TK, Carlson RW, Geheb MA. Hypocalcemia and hypophosphatemia in acutely ill patients. Crit Care Clin. 1987;3:927–941.PubMedGoogle Scholar
  105. 105.
    O’Connor LR, Wheeler WS, Bethune JE. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med. 1977;297:901–903.PubMedCrossRefGoogle Scholar
  106. 106.
    Aubier M, Murciano D, Lecocguic Y, et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985;313:420–424.PubMedCrossRefGoogle Scholar
  107. 107.
    Newman JH, Neff TA, Ziporin P. Acute respiratory failure associated with hypophosphatemia. N Engl J Med. 1977;296:1101–1103.PubMedCrossRefGoogle Scholar
  108. 108.
    Agusti AG, Torres A, Estopa R, Agustividal A. Hypophosphatemia as a cause of failed weaning: the importance of metabolic factors. Crit Care Med. 1984;12:142–143.PubMedCrossRefGoogle Scholar
  109. 109.
    Kingston MA, Al-Siba’i MB. Treatment of severe hypophosphatemia. Crit Care Med. 1985;13:16–18.PubMedCrossRefGoogle Scholar
  110. 110.
    Lentz RD, Brown DM, Kjellstrand CM. Treatment of severe hypophosphatemia. Ann Intern Med. 1978;89:941–944.PubMedCrossRefGoogle Scholar
  111. 111.
    Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977;137:203–220.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Flávio Eduardo Nácul
    • 1
  1. 1.Intensive Care MedicineUniversity Hospital of the Federal University of Rio de JaneiroRio de JaneiroBrazil

Personalised recommendations